[Pediatric autoimmune digestive diseases]

Area of Science:

• Pediatric Gastroenterology and Hepatology
• Immunology
• Microbiome Research

Background:

• Autoimmune diseases including inflammatory bowel diseases (IBD), celiac disease, and autoimmune hepatitis present significant challenges in pediatric care.
• These conditions exhibit increasing incidence, high morbidity, and a considerable impact on children's quality of life.
• Shared pathophysiological mechanisms involve genetic predisposition, microbiome alterations, and environmental/immunological factors.

Purpose of the Study:

• To review the pathophysiology of common pediatric autoimmune gastrointestinal and liver diseases.
• To outline current diagnostic strategies for these challenging conditions.
• To discuss established treatments and explore future perspectives in management.

Main Methods:

• Literature review focusing on pathophysiology, diagnosis, and treatment of pediatric autoimmune gastrointestinal and liver diseases.
• Synthesis of current evidence on genetic, microbiome, environmental, and immunological factors.
• Analysis of management approaches and future research directions.

Main Results:

• Common autoimmune pediatric GI and liver diseases share complex etiologies.
• Early and accurate diagnosis is critical for effective management.
• Multidisciplinary care improves patient outcomes and quality of life.

Conclusions:

• Understanding the shared pathophysiology is key to managing pediatric autoimmune GI and liver diseases.
• Integrated, multidisciplinary management strategies are essential for optimizing care.
• Further research into novel therapeutic targets and personalized medicine approaches is warranted.